Buy Stocks Easy | About Us
January 26, 2021
Buy Stocks Easy | Online Stocks

VRNA


Buy Verona Pharma plc Stock (symbol: VRNA) Easy Online

Company Name: Verona Pharma plc

Symbol: VRNA

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2017

VRNA Current Share Price

Today's VRNA ( Verona Pharma plc ) opening price: $

Yesterday's VRNA ( Verona Pharma plc ) closing price: $

Verona Pharma plc Stock ( symbol: VRNA ) Price Chart since IPO (2017):

12 Months Verona Pharma plc Stock ( symbol: VRNA ) Price Chart

Popular Questions about Verona Pharma plc Public Stock ( VRNA )

A: Verona Pharma plc stock symbol (also called stock or share ticker) is VRNA

A: Verona Pharma plc IPO (Initial Public Offering) took place on 2017

A: Verona Pharma plc's stock (VRNA symbol) price at ther IPO (initial Public Offering) was $

Q: Is VRNA stock worth buying at the moment?

A: The VRNA stock performance since 2019 are rather disappointing. If you had bought 1 share of Verona Pharma plc stock (symbol: VRNA) at the beginning of 2019, at the opening share price of $5.8160, you would be left with exactly $ - which means a waste of your money and time. - SHOW ONLY IF equal or loose.

Buy Verona Pharma plc Stock Easy Online

Verona Pharma plc Stock Ticker Price Chart since IPO:





Verona Pharma plc Stock Price Yesterday



 


Verona Pharma plc Stock Price – Last Week




 


Verona Pharma plc Stock Price – Last Month




 


Verona Pharma plc Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            https://www.marketwatch.com/story/verona-pharma-shares-shoot-higher-on-phase-2-trial-of-respiratory-drug-2020-01-13
                            

                                
Verona Pharma shares shoot higher on Phase 2 trial of respiratory drug

                                
                                
Verona Pharma   surged 69% in London trade as the biopharma said a ...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2020/01/13/1969219/0/en/Verona-Pharma-Reports-Positive-Top-line-Data-in-4-Week-Phase-2b-COPD-Study-with-Nebulized-Ensifentrine-on-Top-of-Tiotropium-Therapy.html
                            

                                
Verona Pharma Reports Positive Top-line Data in 4 Week Phase 2b COPD Study with Nebulized Ensifentrine on Top of Tiotropium Therapy

                                
                                
Primary endpoint met at all doses: ensifentrine produced clinically...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2020/01/07/1966942/0/en/Verona-Pharma-Appoints-David-Moskowitz-as-Vice-President-Capital-Markets-Strategy-Investor-Relations.html
                            

                                
Verona Pharma Appoints David Moskowitz as Vice President, Capital Markets Strategy & Investor Relations

                                
                                
LONDON, Jan.  07, 2020  (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/28/1953604/0/en/Holding-s-in-Company-TR-1-Standard-form-for-notification-of-major-holdings.html
                            

                                
Holding(s) in Company TR-1: Standard form for notification of major holdings

                                
                                
LONDON, Nov.  28, 2019  (GLOBE NEWSWIRE) -- TR-1: S tandard form fo...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/27/1953021/0/en/Verona-Pharma-plc-Grant-of-Options-to-PDMR.html
                            

                                
Verona Pharma plc: Grant of Options to PDMR

                                
                                
LONDON, Nov.  27, 2019  (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/18/1948365/0/en/Verona-Pharma-plc-PDMR-Dealing-Purchase-by-Chairman.html
                            

                                
Verona Pharma plc: PDMR Dealing – Purchase by Chairman

                                
                                
LONDON, Nov.  18, 2019  (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4305058-verona-pharma-plc-vrna-ceo-jan-anders-karlsson-q3-2019-results-earnings-call-transcript
                            

                                
Verona Pharma plc (VRNA) CEO Jan-Anders Karlsson on Q3 2019 Results - Earnings Call Transcript

                                
                                
Verona Pharma plc (VRNA) CEO Jan-Anders Karlsson on Q3 2019 Results...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/05/1940847/0/en/Verona-Pharma-plc-Operational-Update-and-Financial-Results-for-the-Three-and-Nine-Months-Ended-September-30-2019.html
                            

                                
Verona Pharma plc Operational Update and Financial Results for the Three and Nine Months Ended September 30, 2019

                                
                                
Reported positive Phase 2 data with dry powder inhaler formulation


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/29/1936747/0/en/Verona-Pharma-to-Announce-Financial-Results-for-the-Three-and-Nine-Months-Ended-September-30-2019-and-Provide-Clinical-Development-Update.html
                            

                                
Verona Pharma to Announce Financial Results for the Three and Nine Months Ended September 30, 2019 and Provide Clinical Development Update

                                
                                
LONDON, Oct.  29, 2019  (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/17/1930951/0/en/Verona-Pharma-Completes-Enrollment-in-Phase-2b-Clinical-Trial-with-Nebulized-Ensifentrine-in-moderate-to-severe-COPD.html
                            

                                
Verona Pharma Completes Enrollment in Phase 2b Clinical Trial with Nebulized Ensifentrine in moderate-to-severe COPD

                                
                                
Results to Inform Development Plan and Dose Selection for Phase 3 R...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.